Approximate entropy decreases in insulin oscillations for subjects with type 2 diabetes.

被引:0
|
作者
Fidel, M [1 ]
Pinon, I [1 ]
Qualls, C [1 ]
机构
[1] Univ New Mexico, Sch Med, Gen Clin Res Ctr, Albuquerque, NM 87131 USA
关键词
D O I
10.1097/00042871-200401001-00039
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S85 / S85
页数:1
相关论文
共 50 条
  • [21] Indomethacin decreases insulin secretion in type 2 diabetes mellitus
    Arias, AMP
    Romijn, JA
    Corssmit, EPM
    Ackermans, MT
    Nijpels, G
    Endert, E
    Sauerwein, HP
    DIABETOLOGIA, 1999, 42 : A153 - A153
  • [22] Impact of celiac autoimmunity on subjects with type 1 diabetes.
    Simmons, JH
    Emery, LM
    Klingensmith, GJ
    Zarzycki, K
    Taki, I
    Liu, E
    Rewers, M
    Hoffenberg, EJ
    JOURNAL OF INVESTIGATIVE MEDICINE, 2005, 53 (01) : S147 - S147
  • [23] Nephropathy in type 2 diabetes.
    Vandor, T
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (06): : 441 - 441
  • [24] Premixed insulin aspart 30: Control and convenience in Type 1 and Type 2 diabetes.
    Boehm, B
    Home, PD
    Bott, U
    Behrend, C
    Kamp, NM
    Lindholm, A
    DIABETOLOGIA, 2000, 43 : A200 - A200
  • [25] Preserved endothelium-dependent vasodilation in subjects with uncomplicated type 2 diabetes.
    Cockcroft, JR
    White, DJ
    Page, SR
    Gazis, AG
    DIABETOLOGIA, 1998, 41 : A312 - A312
  • [26] Liver fat content, insulin absorption and action as determinants of insulin requirements in type 2 diabetes.
    Ryysy, L
    Häkkinen, AM
    Goto, T
    Vehkavaara, S
    Westerbacka, J
    Halavaara, J
    Yki-Järvinen, H
    DIABETOLOGIA, 1999, 42 : A83 - A83
  • [27] Basal and insulin stimulated levels of insulin signaling proteins in skeletal muscle in Type 2 diabetes.
    Worrall, DS
    Yu, J
    Ofrecio, J
    Frias, J
    Olefsky, JM
    Kruszynska, YT
    JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (01) : 75A - 75A
  • [28] Retinol-binding protein 4, insulin resistance, and type 2 diabetes.
    Polonsky, KS
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (24): : 2596 - 2598
  • [29] Treatment with insulin detemir is associated with predictable fasting blood glucose levels and favourable weight development in subjects with Type 2 diabetes.
    Haak, T
    Tiengo, A
    Waldhäusl, W
    Draeger, E
    DIABETOLOGIA, 2003, 46 : A273 - A273
  • [30] The effect of insulin aspart on postprandial metabolism and metabolic outcome in Type 2 diabetes.
    Gallagher, A
    Home, PD
    DIABETOLOGIA, 2001, 44 : A209 - A209